At Biopôle since 2016.

Abionic is an innovative point-of-care (POC) diagnostic company founded by Dr. Nicolas Durand and Dr. Iwan Märki in 2010 as a spin-off from EPFL, the most well-known Swiss Federal Institute of Technology of Lausanne in Switzerland.

At Abionic, we aim to improve patient care through our disruptive nanofluidic technology based POC abioSCOPE solutions.

For Sepsis, every hour matters.

Our novel sepsis biomarker Pancreatic Stone Protein (PSP) Testing on the abioSCOPE offers PSP result in just 5 minutes with a fingerstick, supports the earliest detection of sepsis, and enables physicians to make critical decision at the point of need.